MoneyWorks4Me

Fredun Pharmaceuticals informs about board meeting

31 May 2017 Evaluate

Fredun Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on May 30, 2017, has transacted the Final Dividend at the rate of 6% to Equity Shareholders was approved by the Board and decided to be proposed for Shareholders approval at the upcoming Annual General Meeting.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..